Steno780G Follow-up Study
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial is a follow-up study for people who already took part in the original Steno780G study. It will check how participants are doing over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the earlier Steno780G study.
- You must follow the study rules as explained by the research team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the Medtronic 780G insulin pump helps people with type 1 diabetes and gastroparesis (slowed stomach emptying) control their blood sugar better than their usual care. It requires continuous glucose monitoring and certain blood sugar levels.
This trial studies how the Medtronic 780G “closed-loop” insulin system works for young people with type 1 diabetes. It may help by improving how automatically insulin is delivered, depending on your body’s needs.
This study is looking at how keeping your blood sugar in a healthy range (called 'time in range') affects the health of your blood vessels and heart in people with type 1 diabetes. It uses a special automated insulin delivery system to help you stay in range.
This trial is testing the best timing for bolus insulin doses (before vs. during a meal) in people using the MiniMed 780G pump. It may help you learn how to better manage your blood sugar after meals.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.